MedPath

TO COMPARE 15% TRICHLOROACETIC ACID PEEL WITH TOPICAL 0.05% TRETINOIN CREAM IN THE TREATMENT OF ACANTHOSIS NIGRICANS

Phase 4
Conditions
Health Condition 1: L83- Acanthosis nigricans
Registration Number
CTRI/2023/07/055355
Lead Sponsor
DEPARTMENT OF DERMATOLOGY
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with acanthosis nigricans

willing to participate in study

Exclusion Criteria

Patients below 18 years and more than 60 years

Pregnant and lactating mothers

Patients not willing for the study

Patients allergic to TCA and Tretinoin

Patients planning for pregnancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The degree of improvement will be assessed using grading system i.e., 0-25% - minimal improvement, 26-50% - moderate improvement, 51-75% - good improvement, 75% - excellent improvement.Timepoint: monthly for 1 year
Secondary Outcome Measures
NameTimeMethod
side effectsTimepoint: monthly for 1 year
© Copyright 2025. All Rights Reserved by MedPath